Table 1.

Effect of imetelstat on genotype of hematopoietic colonies (CFU-GM) assayed from MF CD34+ cells

Cytokines + vehicleCytokines + MM (7.5 μM)Cytokines + Ime (7.5 μM)
% JAK2V617F% Homozygous JAK2V617F% JAK2V617F% Homozygous JAK2V617F% JAK2V617F% Homozygous JAK2V617F
Pt 5 38 (6/16)* 31 (5/16) 56 (15/27) 52 (14/27) 9 (2/23) 0 (0/23) 
Pt 6 100 (27/27) 89 (24/27) 100 (22/22) 82 (18/22) 100 (30/30) 97 (29/30) 
Pt 7 64 (9/14) 36 (5/14) 72 (13/18) 22 (4/18) 60 (12/20) 20 (4/20) 
Pt 8 100 (20/20) 80 (16/20) 100 (21/21) 90 (19/21) 100 (11/11) 73 (8/11) 
Pt 12 63 (19/30) 37 (11/30) 80 (20/25) 56 (14/25) 82 (25/31) 39 (12/31) 
Pt 13 96 (25/26) 81 (21/26) 86 (19/22) 68 (15/22) 70 (14/20) 50 (10/20) 
Cytokines + vehicleCytokines + MM (7.5 μM)Cytokines + Ime (7.5 μM)
% JAK2V617F% Homozygous JAK2V617F% JAK2V617F% Homozygous JAK2V617F% JAK2V617F% Homozygous JAK2V617F
Pt 5 38 (6/16)* 31 (5/16) 56 (15/27) 52 (14/27) 9 (2/23) 0 (0/23) 
Pt 6 100 (27/27) 89 (24/27) 100 (22/22) 82 (18/22) 100 (30/30) 97 (29/30) 
Pt 7 64 (9/14) 36 (5/14) 72 (13/18) 22 (4/18) 60 (12/20) 20 (4/20) 
Pt 8 100 (20/20) 80 (16/20) 100 (21/21) 90 (19/21) 100 (11/11) 73 (8/11) 
Pt 12 63 (19/30) 37 (11/30) 80 (20/25) 56 (14/25) 82 (25/31) 39 (12/31) 
Pt 13 96 (25/26) 81 (21/26) 86 (19/22) 68 (15/22) 70 (14/20) 50 (10/20) 

Individual colonies (CFU-GM) from 6 JAK2V617F+ MF patients (JAK2V617F allele burden: 25%-90%) treated with cytokines alone or cytokines plus imetelstat or MM (7.5 μM) were plucked and genotyped for the JAK2V617F. In 3 of 4 patients (Pts 5, 7, 12, 13) having a reservoir of wild-type JAK2, imetelstat treatment reduced the percent of JAK2V617F+ colonies and percent of homozygous JAK2V617F+ colonies generated.

*

The numbers in parentheses denote the actual number of total JAK2V617F+ or homozygous JAK2V617F+ CFU-GM/the total numbers of CFU-GM plucked and genotyped.

or Create an Account

Close Modal
Close Modal